Cogent Biosciences | ARS:年度报告
04/23 16:41 (美东)
Cogent Biosciences | DEFA14A:其他
04/23 16:38 (美东)
Cogent Biosciences | DEF 14A:股东委托书决议
04/23 16:38 (美东)
Cogent Biosciences | PRE 14A:并购重组委托声明
04/12 16:36 (美东)
Cogent Biosciences | EFFECT:其他
04/11 06:04 (美东)
Cogent Biosciences | 4:持股变动声明-董事 Ferrante Karen Jean
04/02 18:25 (美东)
Cogent Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(9.90%),Fairmount Healthcare Fund II GP LLC(9.90%)等
04/01 18:33 (美东)
Cogent Biosciences | 4:持股变动声明-董事 Fairmount Funds Management LLC
04/01 18:23 (美东)
Cogent Biosciences | S-3:特定交易注册声明
03/29 16:14 (美东)
Cogent Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(9.90%),Fairmount Healthcare Fund II GP LLC(9.90%)等
03/27 16:41 (美东)
Cogent Biosciences | 8-K:重大事件
03/22 08:36 (美东)
Cogent Biosciences | S-8:员工福利计划证券登记
02/26 16:37 (美东)
Cogent Biosciences | 10-K:年度报表
02/26 09:15 (美东)
Cogent Biosciences | 8-K:Cogent Biosciences报告了最近的业务亮点以及2023年第四季度和全年财务业绩
02/26 08:35 (美东)
Cogent Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(18.89%),Fairmount Healthcare Fund II GP LLC(15.99%)等
02/16 18:57 (美东)
Cogent Biosciences | 4:持股变动声明-股东 Fairmount Funds Management LLC
02/16 18:47 (美东)
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(9.99%),VHCP Co-Investment Holdings II, LLC(9.99%)等
02/14 20:38 (美东)
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Commodore Capital LP(7.1%),Commodore Capital Master LP(7.1%)
02/14 18:08 (美东)
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%)等
02/14 17:32 (美东)
Cogent Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Steven A. Cohen(6.1%),Point72 Asset Management, L.P.(6.0%)等
02/14 16:20 (美东)
暂无数据
暂无数据